Simplex Trading’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,236
| Closed | -$16.7K | – | 11009 |
|
|
2021
Q1 | $15K | Buy |
3,236
+2,791
| +627% | +$14.6K | ﹤0.01% | 7693 |
|
|
2020
Q4 | $1K | Buy |
445
+141
| +46% | +$603 | ﹤0.01% | 8204 |
|
|
2020
Q3 | $1K | Buy |
+304
| New | +$1.18K | ﹤0.01% | 7648 |
|
|
2020
Q2 | – | Sell |
-37,509
| Closed | -$108K | – | 8693 |
|
|
2020
Q1 | $108K | Sell |
37,509
-4,679
| -11% | -$21K | ﹤0.01% | 4294 |
|
|
2019
Q4 | $159K | Buy |
42,188
+28,197
| +202% | +$135K | ﹤0.01% | 4003 |
|
|
2019
Q3 | $71K | Buy |
13,991
+6,417
| +85% | +$39.6K | ﹤0.01% | 4689 |
|
|
2019
Q2 | $46K | Sell |
7,574
-1,943
| -20% | -$11.2K | ﹤0.01% | 4936 |
|
|
2019
Q1 | $67K | Buy |
9,517
+7,665
| +414% | +$68.9K | ﹤0.01% | 4755 |
|
|
2018
Q4 | $15K | Sell |
1,852
-16,649
| -90% | -$217K | ﹤0.01% | 5593 |
|
|
2018
Q3 | $370K | Buy |
18,501
+13,137
| +245% | +$308K | ﹤0.01% | 2939 |
|
|
2018
Q2 | $138K | Buy |
5,364
+1,230
| +30% | +$34.1K | ﹤0.01% | 3917 |
|
|
2018
Q1 | $98K | Buy |
+4,134
| New | +$130K | ﹤0.01% | 1823 |
|
|
2017
Q4 | – | Sell |
-36,024
| Closed | -$1.01M | – | 6984 |
|
|
2017
Q3 | $762K | Buy |
+36,024
| New | +$660K | 0.03% | 475 |
|
|
2016
Q1 | – | Sell |
-15,281
| Closed | -$432K | – | 6513 |
|
|
2015
Q4 | $432K | Buy |
+15,281
| New | +$257K | 0.03% | 487 |
|
Simplex Trading's ADMS Position: Q2 2021 in Review
Simplex Trading sold out of Adamas Pharmaceuticals (ADMS) in Q2 2021, closing a stake of 3,236 shares — an estimated $16.7K sold.
Simplex Trading first reported a position in ADMS in Q4 2015 and held it in 14 quarters. The position peaked at $762K in Q3 2017. 67 funds tracked by Wall St. Rank hold ADMS as of Q2 2021.
- Simplex Trading reported no remaining Adamas Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 3,236 Adamas Pharmaceuticals shares in Q2 2021, an estimated $16.7K.
- Simplex Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 14 quarters.
- Simplex Trading's Adamas Pharmaceuticals position peaked at $762K in Q3 2017.
- 67 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.